Severe Hemophilia A Completed Phase 3 Trials for Efmoroctocog alfa (DB11607)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02502149Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) ScaleOther